Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Mechanism of N-Hydroxy-2-Acetylaminofluorene Mutagenicity in the Salmonella Test System

Role of N-O Acyltransferase and Sulfotransferase from Rat Liver

PETER J. WIRTH and SNORRI S. THORGEIRSSON
Molecular Pharmacology March 1981, 19 (2) 337-344;
PETER J. WIRTH
Biochemical Pharmacology Section, Laboratory of Chemical Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SNORRI S. THORGEIRSSON
Biochemical Pharmacology Section, Laboratory of Chemical Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

N-Hydroxy-2-acetylaminofluorene N-O acyltransferase and sulfotransferase were purified from male Sprague-Dawley rat liver, and the partially purified enzyme fractions were used to evaluate the role of each enzyme in the metabolic and mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella mutagenesis system. Partially purified N-O acyltransferase was approximately 5 times as active as rat liver 105,000 x g supernatant in its ability to activate N-hydroxy-2-acetylaminofluorene to a mutagen in the Salmonella test system. The addition of either ascorbate (2 mM) or NADPH (1 mM) markedly increased the mutagenicity of N-hydroxy-2-acetylaminofluorene, whereas the addition of either paraoxon (10-6 M) or 3'-phosphoadenosine-5'-phosphosulfate had no effect on the mutagenicity of N-hydroxy-2-acetylaminofluorene mediated by N-O acyltransferase. N-O acyltransferase also activated N-hydroxy-2-acetylaminofluorene in vitro to a species which formed covalent nucleic acid-aminofluorene adducts with yeast tRNA. Adduct formation was markedly inhibited by either ascorbate or NADPH but unaffected by the addition of either paraoxon or 3'-phosphoadenosine-5'-phosphosulfate. Similarly, partially purified sulfotransferase catalyzed the covalent binding in vitro of N-hydroxy-2-acetylaminofluorene to tRNA. The addition of 3'-phosphoadenosine-5'-phosphosulfate markedly increased (60-fold) the extent of adduct formation, whereas ascorbate (2 mM) and NADPH (1 mM) markedly inhibited the covalent binding of N-hydroxy-2 acetylaminofluorene to tRNA. The addition of 3'-phosphoadenosine-5'-phosphosulfate in combination with either ascorbate or NADPH resulted in a marked increase (50- to 70-fold) in the extent of covalent binding of N-hydroxy-2-acetylaminofluorene, although the total amount bound was only 10-20% of that observed with 3'-phosphoadenosine-5'-phosphosulfate alone. However, in contrast to N-O acyltransferase, purified rat liver sulfotransferase was completely inactive in its capacity to activate N-hydroxy-2-acetylaminofluorene to a mutagen in the Salmonella test system. The addition of either ascorbate or NADPH with or without 3'-phosphoadenosine-5'-phosphosulfate had no effect (no revertants observed) on the mutagenicity of N-hydroxy-2-acetylaminofluorene mediated by sulfotransferase. These data indicate that the initial step in the mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system by rat liver 105,000 x g supernatant is deacetylation via N-O acyltransferase rather than sulfate formation via sulfotransferase.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 2
1 Mar 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mechanism of N-Hydroxy-2-Acetylaminofluorene Mutagenicity in the Salmonella Test System
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Mechanism of N-Hydroxy-2-Acetylaminofluorene Mutagenicity in the Salmonella Test System

PETER J. WIRTH and SNORRI S. THORGEIRSSON
Molecular Pharmacology March 1, 1981, 19 (2) 337-344;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Mechanism of N-Hydroxy-2-Acetylaminofluorene Mutagenicity in the Salmonella Test System

PETER J. WIRTH and SNORRI S. THORGEIRSSON
Molecular Pharmacology March 1, 1981, 19 (2) 337-344;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Michaelis Menten quantification of GPCR-G protein signalling
  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics